AGENDACIRCULATORY SYSTEM DEVICES PANEL
September 11, 2001
Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD
8:00 12:30 First PMA Discussion, Recommendations, and Voting
8:00 a.m. Call to Order Warren Laskey, M.D., Acting Chairperson
8:05 8:15 a.m.* Open Public Hearing*
8:15 9:15 a.m. Sponsor Presentation: CryoLife, Inc
P010003, BioGlueฎ Surgical Adhesive
James C. Vander Wyk, Ph.D., VP Regulatory Affairs and Quality Assurance, CryoLife, Inc.
David M. Fronk, VP Clinical Resarch, CryoLife, Inc.
Joseph S. Coselli, MD, Baylor College of Medicine
Joseph E. Bavaria, MD, Hospital of the University of Pennsylvania
9:15 9:30 a.m. FDA Presentation
Lisa Kennell, lead reviewer
9:30 12:15 p.m. Open Committee Discussion, Recommendations, Warren
10:15 10:30 a.m. Break
12:15 12:30 p.m.* Open Public Hearing*
12:30 p.m. Adjourn Break for Lunch
1:30 6:00 p.m. Second PMA Discussion, Recommendations, and Voting
1:30 p.m. Call to Order Warren Laskey, M.D.
1:35 1:45 p.m.* Open Public Hearing*
1:45 2:45 p.m. Sponsor Presentation: Cohesion Technologies
P010022, CoSeal Surgical Sealant
Frank DeLustro, Ph.D., President and CEO, Cohesion
John Martin, M.D., West Shore Surgical Associates, Annapolis, MD
Mark Glickman, M.D., Virginia Vascular Associates
Ross Erickson, M.D., VP of Regulatory and Clinical Affairs, Cohesion
2:45 3:00 p.m. FDA Presentation
Jennifer Goode, lead reviewer
3:00 5:45 p.m. Open Committee Discussion, Recommendations, Warren Laskey, M.D.
3:45 4:00 p.m. Break
5:45 6:00 p.m.* Open Public Hearing*
6:00 p.m. Adjourn
OPEN PUBLIC HEARINGS*
Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee.
Ms. Moynahan will present the speakers who have requested time for presentation to the Panel. After the scheduled speakers have spoken, the Chair may ask them to remain if the committee wishes to question them further. Dr. Laskey will recognize unscheduled speakers as time allows.
There were no requests to speak during the Open Public Hearings on September 11.
Note: Only the Chair and members of the Panel may question speakers during the open public hearing.